Coloplast A/S CLPBF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.40B | 4.33B | 4.22B | 4.13B | 4.06B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.40B | 4.33B | 4.22B | 4.13B | 4.06B |
| Cost of Revenue | 1.44B | 1.41B | 1.36B | 1.32B | 1.32B |
| Gross Profit | 2.96B | 2.92B | 2.87B | 2.81B | 2.75B |
| SG&A Expenses | 1.65B | 1.62B | 1.59B | 1.55B | 1.52B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -20.82M | -21.11M | -21.52M | -21.30M | -6.12M |
| Total Operating Expenses | 3.23B | 3.17B | 3.07B | 2.99B | 2.96B |
| Operating Income | 1.17B | 1.17B | 1.16B | 1.14B | 1.10B |
| Income Before Tax | 617.97M | 535.86M | 937.20M | 910.86M | 903.49M |
| Income Tax Expenses | 188.94M | 207.70M | 331.29M | 373.49M | 309.56M |
| Earnings from Continuing Operations | 429.03 | 328.16 | 605.91 | 537.37 | 593.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 429.03M | 328.16M | 605.91M | 537.37M | 593.93M |
| EBIT | 1.17B | 1.17B | 1.16B | 1.14B | 1.10B |
| EBITDA | 1.83B | 1.36B | 1.35B | 1.32B | 1.28B |
| EPS Basic | 1.91 | 1.46 | 2.69 | 2.39 | 2.64 |
| Normalized Basic EPS | 3.14 | 2.94 | 2.79 | 2.73 | 2.57 |
| EPS Diluted | 1.90 | 1.46 | 2.69 | 2.38 | 2.64 |
| Normalized Diluted EPS | 3.14 | 2.94 | 2.79 | 2.73 | 2.57 |
| Average Basic Shares Outstanding | 900.80M | 901.00M | 901.20M | 901.20M | 900.80M |
| Average Diluted Shares Outstanding | 900.80M | 901.00M | 901.20M | 901.20M | 900.80M |
| Dividend Per Share | 3.59 | 3.59 | 3.52 | 3.52 | 3.21 |
| Payout Ratio | 187.48% | 244.93% | 132.66% | 133.79% | 121.05% |